Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge

Virology

Volumn 278, Issue 2, 2000, Pages 400-411

  Zuber, Bartek ^a,b,c   Hinkula, Jorma ^a   Vödrös, Dalma ^b   Lundholm, Peter ^a   Nilsson, Charlotta ^a   Mörner, Andreas ^b   Levi, Mikael ^a   Benthin, Reinhold ^a   Wahren, Britta ^a,b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c MEDIVIR AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RECEPTOR ANTIBODY;

ALLELE; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA STRAND BREAKAGE; GENE TARGETING; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INFECTION RISK; MONKEY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA FASCICULARIS;

EID: 0034528144     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0633     Document Type: Article

References (41)

1. β-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge
2. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera
3. DNA-based immunization induces anti-CD4 antibodies directed primarily to native epitopes
4. The influence of MT-2 tropism on the prognostic implications of the delta32 deletion in the CCR-5 gene
5. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
6. Site-directed primary in vitro immunization: Production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors
7. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV- suppressive factors produced by CD8+ T cells
8. Identification of a major co-receptor for primary isolates of HIV-1
9. Expression cloning of new receptors used by simian and human immunodeficiency viruses
10. The CCR5 receptor acts as an alloantigen in CCR5Delta32 homozygous individuals: Identification of chemokine and HIV-1-blocking human antibodies
11. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins
12. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection
13. Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization
14. Epitope mapping of the HIV-1 gag region with monoclonal antibodies
15. Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes
16. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
17. Sensitivity to inhibition by β-chemokines correlates with biological phenotypes of primary HIV-1 isolates
18. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide
19. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
20. Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques
21. CCRS-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro
22. Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA
23. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response
24. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5
25. Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells
26. Universally immunogenic T cell epitopes: Promiscuous binding to human MHC class II and promiscuous recognition by T cells
27. Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo
28. Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts
29. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope
30. DNA vaccines
31. Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxy carbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins
32. Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen
33. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
34. Amplification of T-cell and antibody responses in DNA-based immunization with HIV-1 Nef by co-injection with a GM-CSF expression vector
35. A capture enzyme immunoassay for detection of HIV-2/SIV antigen
36. DNA increases the potency of vaccination against infectious diseases
37. Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex
38. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
39. Immunization of simian immunodeficiency virus-infected rhesus monkeys with soluble human CD4 elicits an antiviral response
40. Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding
41. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro